RCT | Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris.
15 Sep, 2022 | 13:10h | UTCEffect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial – JAMA Dermatology (free for a limited period)
Commentary on Twitter
Itraconazole is highly efficacious at all 3 doses but requires prolonged treatment, and a substantial number of patients relapsed after successful treatment. https://t.co/oOMkvp1WIp #Research pic.twitter.com/PoNYu50Cxr
— JAMA Dermatology (@JAMADerm) September 14, 2022